Mexico Bispecific Antibodies Market Size & Outlook, 2025-2031
Mexico Bispecific Antibodies Market Size
According to Straits Research analysis, the Mexico Bispecific Antibodies Market was valued at USD 34.57 Million in 2024 and is projected to reach USD 95.65 Million by 2031, expanding at a CAGR of 16.5% during the forecast period. This growth is primarily driven by the increasing usage of bispecific antibodies in oncology, autoimmune, and infectious diseases. Rising investments in health sectors and the presence of robust chemical and agricultural industries endorse the growing demand. Emerging opportunities lie in areas of green production methods, improved product sustainability due to technological advancements, and potential exports to North America and Latin America. Mexico, with its burgeoning healthcare infrastructure and dedicated focus on biotechnology research, is progressively cementing its position in the bispecific antibodies market.
Source: Straits Research Analysis Company Publications, Primary Interviews.
Mexico Bispecific Antibodies Market Highlights
- By segment, Bi-specific T-cell engager emerged as the largest Type in terms of market size in 2024.
- Bi-specific T-cell engager is anticipated to remain the most attractive Type segment, recording the fastest growth during the forecast period.
- As of 2024, Mexico held 0.63% of the global bispecific antibodies market size.
- By 2031, United States is anticipated to capture the largest share of the global bispecific antibodies market.
- In Latin America, Rest of Latin America is expected to lead the regional bispecific antibodies market size by 2031.
- Mexico will remain the fastest-growing market in Latin America, reaching USD 46.97 Million by 2031.
- 📊 Preview Report Scope and Structure – Gain immediate visibility into key topics, market segments, and data frameworks covered.
- 📥 Evaluate Strategic Insights – Access selected charts, statistics, and analyst-driven commentary derived from the final report deliverables.
Report Summary
| Report Scope | Details |
|---|---|
| Base Year for Study | 2024 |
| Study Period | 2021-2031 |
| Historical Period | 2021-2023 |
| Forecast Period | 2025-2031 |
| Market Size In 2024 | USD 34.57 Million |
| Market Size In 2031 | USD 95.65 Million |
| Largest segment | Bi-specific T-cell engager |
| Fastest segment | Bi-specific T-cell engager |
| Units | Revenue in USD Million |
| CAGR | 16.5% (2025-2031) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends |
Mexico Bispecific Antibodies Market Share By Type
Segmentation Covered
| Segments | Sub Segments |
|---|---|
| Type |
|
| Therapeutic Areas |
|
| Target |
|
Mexico Bispecific Antibodies Market By Type 2031
Source: Straits Research Analysis Company Publications, Primary Interviews.
Mexico Bispecific Antibodies Market By Therapeutic Areas 2031
Source: Straits Research Analysis Company Publications, Primary Interviews.
Mexico Bispecific Antibodies Market By Target 2031
Source: Straits Research Analysis Company Publications, Primary Interviews.
